(CIA) Citizens - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1747401008
CIA: Life Insurance, Final Expense Insurance, Property Insurance, Accident Insurance
Citizens, Inc. provides life insurance products in the United States and internationally. The company operates in two segments, Life Insurance and Home Service Insurance. The Life Insurance segment issues ordinary whole life insurance and endowment policies in the United States dollar-denominated amounts to non-U.S. residents in through independent marketing agencies and consultants. The Home Service Insurance segment offers final expense life insurance and property insurance policies to middle-and lower-income households, as well as whole life products in Louisiana, Mississippi, and Arkansas. This segment provides its products and services through funeral homes and independent agents. The company provides accident and health insurance policies. Citizens, Inc. was founded in 1969 and is headquartered in Austin, Texas., Web URL: https://www.citizensinc.com
Additional Sources for CIA Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CIA Stock Overview
| Market Cap in USD | 259m |
| Sector | Financial Services |
| Industry | Insurance - Life |
| GiC Sub-Industry | Life & Health Insurance |
| IPO / Inception | 1988-12-05 |
CIA Stock Ratings
| Growth 5y | -14.2% |
| Fundamental | -9.07% |
| Dividend | 0.0% |
| Rel. Strength Industry | 38.3 |
| Analysts | - |
| Fair Price Momentum | 5.08 USD |
| Fair Price DCF | 3.81 USD |
CIA Dividends
No Dividends PaidCIA Growth Ratios
| Growth Correlation 3m | 59.2% |
| Growth Correlation 12m | 88.7% |
| Growth Correlation 5y | -71.3% |
| CAGR 5y | -4.14% |
| CAGR/Max DD 5y | -0.05 |
| Sharpe Ratio 12m | 1.27 |
| Alpha | 68.47 |
| Beta | 1.10 |
| Volatility | 46.38% |
| Current Volume | 209.9k |
| Average Volume 20d | 122.6k |
What is the price of CIA stocks?
As of February 23, 2025, the stock is trading at USD 5.18 with a total of 209,871 shares traded.
Over the past week, the price has changed by -3.54%, over one month by +11.40%, over three months by +7.92% and over the past year by +79.86%.
As of February 23, 2025, the stock is trading at USD 5.18 with a total of 209,871 shares traded.
Over the past week, the price has changed by -3.54%, over one month by +11.40%, over three months by +7.92% and over the past year by +79.86%.
Is Citizens a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Citizens is currently (February 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -9.07 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CIA as of February 2025 is 5.08. This means that CIA is currently overvalued and has a potential downside of -1.93%.
Neither. Based on ValueRay Fundamental Analyses, Citizens is currently (February 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -9.07 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CIA as of February 2025 is 5.08. This means that CIA is currently overvalued and has a potential downside of -1.93%.
Is CIA a buy, sell or hold?
Citizens has no consensus analysts rating.
Citizens has no consensus analysts rating.
What are the forecast for CIA stock price target?
According to ValueRays Forecast Model, CIA Citizens will be worth about 6.1 in February 2026. The stock is currently trading at 5.18. This means that the stock has a potential upside of +17.76%.
According to ValueRays Forecast Model, CIA Citizens will be worth about 6.1 in February 2026. The stock is currently trading at 5.18. This means that the stock has a potential upside of +17.76%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 5 | -3.5% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 6.1 | 17.8% |